Health

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:  Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.…

10 months ago

Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption

July 29, 2025 09:01 ET  | Source: Windtree Therapeutics Investors choose to redeem or convert the majority of Series C…

10 months ago

NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion

July 29, 2025 09:00 ET  | Source: NewGenIvf Limited The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting…

10 months ago

AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering

OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing…

10 months ago

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company…

10 months ago

Can-Fite Announces Up To $15.0 Million Public Offering

July 28, 2025 12:24 ET  | Source: Can-Fite BioPharma Ltd. $5.0 million upfront with up to an additional $10.0 million…

10 months ago

Floe Health Launches to Power Intelligence at Every Patient Touchpoint

July 28, 2025 12:04 ET  | Source: Floe Health San Francisco, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Floe Health,…

10 months ago

Testosterone Booster for Muscle Gain: Men Opt for OTC Supplement Form Natural Testosterone Replacement Therapy (TRT) Treatment in 2025

New York City, NY, July 27, 2025 (GLOBE NEWSWIRE) -- A recent survey shows that TestoPrime is widely regarded by…

10 months ago

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

July 25, 2025 16:05 ET  | Source: atai Life Sciences Initial results demonstrate numerical improvement of cognitive and functional measures…

10 months ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

July 25, 2025 16:05 ET  | Source: iRadimed Corporation ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD)…

10 months ago